Setting Sail for a New Chapter in Digital Marketing: Sanofi and MedSci Announce Strategic Collaboration

On the afternoon of May 31, Sanofi and MedSci successfully held an online signing ceremony for their strategic digital cooperation.Xia Chun, Head of Greater China for Sanofi’s Primary Care Business Unit; Liu Jie, Head of Strategic Partnerships; and other members of the management teamandFan Jie, CEO of MedSci; Sun Chao, Deputy General Manager; and other management representativesAttended the signing ceremony.

At the signing ceremony, Xia Chun, Head of Greater China for Sanofi’s General Medicines Business Unit, and Fan Jie, CEO of MedSci, formally signed a strategic cooperation agreement on digitalization.Both parties will actively collaborate in areas such as digital academic dissemination, development of digital platforms, empowerment of virtual representatives, digital patient-physician education, and market intelligence research.。

Sanofi is a global leader in innovative pharmaceuticals and healthcare, driven by its mission to pursue the miracles of science and improve people’s lives. As one of the first multinational corporations to enter China after the launch of the country’s reform and opening-up policy, Sanofi has worked hand in hand with China for the past 40 years. It has accelerated the introduction of innovative medicines and vaccines, continuously transformed medical practice, benefited more Chinese citizens, and jointly created a better life. MedSci boasts strong academic expertise through its team of PhDs in medicine and biology from renowned universities worldwide. In scientific research and academia, it offers extensive project experience and platform tools covering clinical study design, database establishment, medical statistics, publication planning, and results promotion. By providing comprehensive solutions for clinical research, MedSci promotes the sharing, collaborative translation, and dissemination of clinical research findings.

Xia Chun, Head of Greater China for Sanofi’s General Medicines Business Unit, stated that the products covered under the comprehensive collaboration between Sanofi and MedSci encompass the fields of rheumatology and immunology, psychiatry, and endocrinology. MedSci will conduct marketing activities through a digital marketing model, providing physicians with more comprehensive disease management solutions and offering patients improved quality of life and greater opportunities for disease cure.

It is reported that Sanofi and MedSci have launched a digital marketing collaboration for products in the aforementioned fields since May 2022. Currently, the partnership is proceeding in an orderly manner toward its established objectives and has received positive feedback from the market. Through preliminary discussions on business models, both parties have further explored opportunities for cooperation. Starting in June, Sanofi will include certain cardiovascular products in their joint digital marketing initiative.

Sun Chao, Head of the APO Division at MedSci, stated that the MedSci APO team will help Sanofi benefit from precise screening and broad reach, digital academic empowerment, and efficient, low-cost delivery of medical information, thereby creating a closed-loop digital academic marketing system.

In terms of precise screening and broad outreach, MedSci has accumulated a large base of high-value physician clients through years of deep medical services. Leveraging its physician profiling system, MedSci can help enterprises precisely identify key physicians and rapidly reach target audiences on a broad scale, thereby addressing corporate needs for physician evaluation and screening at various stages while ensuring extensive and swift engagement with target physicians. Secondly, regarding digital academic empowerment, MedSci’s professional medical team has continuously enhanced academic support for physicians over the years. With a profound understanding of physicians’ unmet academic needs, the team can align with corporate objectives and match physicians’ varying levels of cognitive awareness to customize high-quality medical content, thus solving the challenge of designing differentiated medical information services for enterprises at different development stages. Thirdly, in terms of efficient and cost-effective dissemination of medical information, MedSci’s professional online iMSL (interactive Medical Science Liaison) team, combined with its offline field promotion team, enables low-cost, rapid, and efficient delivery of academic information compared to traditional marketing models. Relying on its self-built SCRM (Social Customer Relationship Management) digital middle platform, MedSci efficiently integrates online and offline communication and collaboration processes, addressing challenges such as excessive labor costs and the inability to standardize marketing workflows. Finally, through its APO (Academic Promotion Optimization) digital marketing solution, MedSci helps enterprises rapidly expand their physician coverage, promote physicians’ academic awareness and perceptions through multi-channel approaches, and provide real-time quantification of service processes and outcomes. This aligns with the industry trend toward compliant and transparent marketing, resolves difficulties in evaluating the effectiveness of academic services, and supports the healthy and sustainable development of enterprises.

MedSci’s APO digital academic empowerment demonstrates significant advantages. Sun Chao, Head of MedSci’s APO Division, highlighted that its core strengths are primarily reflected in three key areas. First, MedSci has accumulated a vast physician database through years of operational experience. Second, MedSci has developed an advanced digital remote management system, including intelligent SCRM systems, to deliver precise digital empowerment. Third, MedSci boasts an experienced and professional iMSL online team with a comprehensive training framework, responsible for online physician recruitment, perception surveys, and academic promotion visits.

Sanofi and MedSci Join Forces to Empower Chronic Disease Management for Patients and Physicians Through Digital Solutions, Enhance Drug Accessibility, and Support the Healthy China Initiative.

Sanofi is a global leader in innovative healthcare. Our mission is to pursue the miracles of science and improve people’s lives. With a presence in more than 100 countries, Sanofi is committed to transforming medical practice and turning the impossible into the possible. We provide potentially life-changing healthcare solutions and vaccines that prevent life-threatening diseases to people around the world, while placing sustainability and social responsibility at the core of our ambitious strategy.

MedSci leverages its professional online physician platform, built over more than a decade of expertise, to connect physicians, patients, and pharmaceutical and medical device companies through big data and artificial intelligence technologies. It provides digital solutions that empower the healthcare ecosystem and improve the quality of medical care. Its business offerings include physician platform solutions, real-world study solutions, and precision omnichannel marketing solutions. Covering specialized services such as pharmaceutical marketing consulting, medical affairs enablement, multichannel academic dissemination, and integrated physician-patient management, MedSci delivers one-stop digital solutions in medical affairs, marketing, market access, and communications for pharmaceutical and medical device enterprises.

MedSci’s independent medical think tank brings together experts and scholars in the healthcare field to exchange industry insights, spark intellectual synergy, and continuously provide in-depth perspectives on medical academia and industry.